Clinical Trials Logo

Clinical Trial Summary

This prospective study will assess Ozurdex in the treatment of Diabetic Macular Oedema in clinical practice.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02731911
Study type Observational
Source Allergan
Contact
Status Completed
Phase
Start date April 29, 2016
Completion date October 22, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04576689 - Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy Phase 2
Completed NCT02554747 - Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa N/A
Withdrawn NCT02309476 - Sub-threshold Photocoagulation of Diabetic Macular Oedema N/A
Terminated NCT02207712 - Noctura400 Treatment for Diabetic Retinopathy (CANDLE) N/A
Completed NCT02457884 - Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema N/A
Completed NCT00148330 - Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study Phase 2/Phase 3
Completed NCT03495765 - To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus Phase 3
Completed NCT00167518 - Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) Phase 2/Phase 3
Completed NCT01787669 - Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema Phase 2
Completed NCT01175070 - Intravitreal Macugen for Ischaemic Diabetic Macular Oedema Phase 4
Terminated NCT00427986 - Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema N/A
Completed NCT00333671 - Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema) N/A
Completed NCT00148265 - A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema Phase 2/Phase 3
Completed NCT02181400 - Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema N/A